HB3017 • 2025

Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Representative Neron
Last action: 2025-06-27
Official status: In House Committee
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products.

Digest: The Act would tell OHA to study the risks to human health of chemicals in some products.

What This Bill Does

Digest: The Act would tell OHA to study the risks to human health of chemicals in some products.
(Flesch Readability Score: 75.1).
Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products.
Directs the authority to submit findings to the interim committees of the Legislative Assembly related to public health no later than September 15, 2026.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2025-06-27 House
In committee upon adjournment.
2025-01-17 House
Referred to Behavioral Health and Health Care with subsequent referral to Ways and Means.
2025-01-13 House
First reading. Referred to Speaker's desk.

Official Summary Text

Digest: The Act would tell OHA to study the risks to human health of chemicals in some products. (Flesch Readability Score: 75.1).
Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products. Directs the authority to submit findings to the interim committees of the Legislative Assembly related to public health no later than September 15, 2026.
Sunsets on January 2, 2027.
Relating to: Relating to chemicals in products.
Current location: In House Committee

Current Bill Text

Read the full stored bill text

1
2
3
4
5
6
7
8
9
10
83rd OREGON LEGISLATIVE ASSEMBLY--2025 Regular Session
House Bill 3017
Sponsored by Representative NERON (Presession filed.)
SUMMARY
The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject
to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the
measure as introduced. The statement includes a measure digest written in compliance with applicable readability
standards.
Digest: The Act would tell OHA to study the risks to human health of chemicals in some pro-
ducts. (Flesch Readability Score: 75.1).
Requires the Oregon Health Authority to study the risks to human health of chemicals in
menstrual, intimate care and incontinence products. Directs the authority to submit findings to the
interim committees of the Legislative Assembly related to public health no later than September 15,
2026.
Sunsets on January 2, 2027.
A BILL FOR AN ACT
Relating to chemicals in products.
Be It Enacted by the People of the State of Oregon:
SECTION 1.
The Oregon Health Authority shall study the risks to human health of
chemicals in menstrual, intimate care and incontinence products. The authority shall submit
a report in the manner provided by ORS 192.245, and may include recommendations for leg-
islation, to the interim committees of the Legislative Assembly related to public health no
later than September 15, 2026.
SECTION 2. Section 1 of this 2025 Act is repealed on January 2, 2027.
NOTE: Matter in boldfaced type in an amended section is new; matter [ italic and bracketed] is existing law to be omitted.
New sections are in boldfaced type.
LC 1745